Tags Clinical trials

Tag: clinical trials

Michael Mansour, MD, PhD

NED Biosystems Announces Infectious Disease Research Scientist Michael Mansour, MD, PhD to Serve as Medical Advisor

CAMBRIDGE, Mass. /Massachusetts Newswire/ -- NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company's Medical Advisor of Infectious Disease.

Aristea Translational Medicine Corp. has initiated development of PhenT, a drug with novel cellular protective properties

PARK CITY, Utah, May 26, 2020 (SEND2PRESS NEWSWIRE) -- Silent Hypoxia is a frequent disabling and sometimes fatal complication in COVID-19 disease. To prevent SARS-CoV-2 coronavirus-induced damage to patients' lungs and Silent Hypoxia in patients, Aristea Translational Medicine Corp. has initiated development of PhenT, a drug with novel cellular protective properties.

ROKiT Pharma Preclinical Studies Show Promise for Naturally Derived Cancer Drug, ROK-001 – Moving Towards The Initiation Of Phase 1b/2 Clinical...

LOS ANGELES, Calif., April 2, 2020 (SEND2PRESS NEWSWIRE) -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.

iCell Gene Therapeutics Announces CAR-T Presentations at 61st American Society of Hematology Annual Meeting

STONY BROOK, N.Y., Nov. 14, 2019 (SEND2PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.

Lip Plumping Leader, CandyLipz Conducts Clinical Trial to Resolve Consumer Cupping Concerns

SAN FRANCISCO, Calif., July 9, 2018 (SEND2PRESS NEWSWIRE) -- When some customers showed concern over cupping marks after using the lip plumper manufactured by CandyLipz, LLC, the company quickly jumped into action. It hired a third-party independent investigative research vendor, Biometrix, Inc -, a company that has conducted clinical trials for major multinational biotech, dermatology, product manufacturers and more for 20 plus years - to prove that there was nothing to worry about.

WHAT'S NEWS